Promoted Content
Promoted Content
pfizer-centreone-m-2021-03-08

nextFEATURED COMPANIESprevious

OUR PARTNER COMPANIES

nextINTERVIEWS #SpeakPharmaprevious SEE
ALL

“For orphan drugs, we identify a patient-ready formulation in less than half the time.”

This week, SpeakPharma interviews Dr. Peter Scholes, Chief Scientific Officer, Quotient Sciences, w...

PharmaCompass.com

“Pfizer CentreOne is distinct from other CDMOs due to the fact that we are embedded within Pfizer”

This week, SpeakPharma interviews Pfizer CentreOne’s Andrew Moore, General Manager, and A...

PharmaCompass.com

“Polpharma API’s ability to control particle size distribution resolves multiple formulation challenges for our clients”

This week, SpeakPharma interviews three experts from Poland’s leading pharmaceutical company, ...

PharmaCompass.com

“CDMOs are modern day kings that attract investments like safe AAA rated bonds”

This week, Frédéric Gaussens, VP Business Development and Strategy, Eurofins CDMO Euro...

PharmaCompass.com

“During the pandemic, digital marketing has become more vital for the success of brands”

The pandemic has been raging across the world for over nine months, with no end in sight. With trad...

PharmaCompass.com

“Wavelength’s strategy to continuously invest in its supply chain has proven itself during the Covid-19 pandemic”

This week, SpeakPharma interviews Ilan Avni, Vice President, Business Development at Wavelength Ph...

PharmaCompass.com

nextNEWS & ALERTSprevious

TOP 10 NEWS OF THE DAY SEE
ALL

NEWS LIBRARY

nextMARKET PLACEprevious

LATEST ENQUIRIES

APIs